WPI 2245 (Mesalamine Delayed-Release 1.2 g)
Pill with imprint WPI 2245 is Brown, Elliptical / Oval and has been identified as Mesalamine Delayed-Release 1.2 g. It is supplied by Actavis Pharma, Inc..
Mesalamine is used in the treatment of ulcerative colitis, maintenance; crohn's disease, maintenance; ulcerative colitis; ulcerative colitis, active; ulcerative proctitis (and more), and belongs to the drug class 5-aminosalicylates. Excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 1.2 g is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 2245
Mesalamine Delayed-Release
- Imprint:
- WPI 2245
- Strength:
- 1.2 g
- Color:
- Brown
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- 5-aminosalicylates
- Pregnancy Category:
- B - No proven risk in humans - excluding Asacol and Asacol HD
C - Risk cannot be ruled out - Asacol and Asacol HD - CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00591-2245
More about mesalamine
- Mesalamine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 277 Reviews
- Drug class: 5-aminosalicylates
Consumer resources
- Mesalamine
- Mesalamine rectal
- Mesalamine Long-Acting Capsules (Apriso)
- Mesalamine Long-Acting Capsules (Delzicol)
- Mesalamine Long-Acting Capsules (Pentasa)
- ... +5 more
Other brands: Lialda, Apriso, Pentasa, Asacol, ... +7 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
